This brand name is authorized in Estonia, Israel, Lithuania, United States
The drug NUEDEXTA contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Demorphan
UNII 9D2RTI9KYH - DEXTROMETHORPHAN HYDROBROMIDE
|
|
Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors. |
|
2
Quinidine
UNII J13S2394HE - QUINIDINE SULFATE
|
|
Quinidine increases plasma levels of dextromethorphan by competitively inhibiting cytochrome P450 2D6 (CYP2D6), which catalyses a major biotransformation pathway for dextromethorphan. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N07XX | Other nervous system drugs | N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1619052, 1619074, 1619085, 1619096 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 6919 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1070755, 1070756, 1070757 |
| Country: US | FDA, National Drug Code | Identifier(s): 64597-301 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
